To the Editor.—

After following-up at 6 years of age the subjects enrolled in the National Institute of Child Health and Human Development Randomized, Controlled Trial of Phototherapy for Neonatal Hyperbilirubinemia, Scheidt et al concluded that this treatment "effectively controlled neonatal hyperbilirubinemia without evidence of adverse outcome at 6 years of age and was at least as effective as management with exchange transfusion alone."1 According to the objective of the study stated in the Abstract and the introduction, the latter "effective" refers to "preventing brain injury."

This content is only available via PDF.
You do not currently have access to this content.